Michael Northend, MBBS BSc MRCP FRCPath^1*, William Wilson^2*, Laura Clifton-Hadley, BSc, PhD^3*, Zaynab Rana, MSc^4*, Tanya-Louise Martin^4*, Moya Young, MBBS, MRCP, FRCPath^5*, Fiona Miall^6*, David Cunningham, MD, FRCP, FMedSci^7*, Jan Walewski, MD, PhD⁸, Burhan Ferhanoglu, MD⁹, Amanda Johnston^10*, John F. Seymour, MBBS, PhD, FRACP¹¹, David C. Linch^12* and Kirit M. Ardeshna¹³

¹University College Hospital, London, United Kingdom
²Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom
³Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
⁴Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom
⁵Kent and Canterbury Hospital, East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom
⁶University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁸Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
⁹Hematology Department, Koç University, School of Medicine, Istanbul, Turkey
¹⁰Westmead Hospital, Westmead, NSW, Australia
¹¹Peter MacCallum Cancer Centre & the Royal Melbourne Hospital, Melbourne, Victoria, Australia
¹²University College London, London, United Kingdom
¹³Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

Martin Dreyling, MD¹, Michael Dickinson, MD², Joaquin Martinez Lopez^3*, Arne Kolstad, MD, PhD^4*, Jason P Butler, MBBS, MMedSc⁵, Monalisa Ghosh, MD⁶, Leslie L. Popplewell, MD, FACP, MPH⁷, Julio Chavez⁸, Emmanuel Bachy, MD, PhD^9*, Koji Kato, MD, PhD^10*, Hideo Harigae, MD, PhD¹¹, Marie Jose Kersten, MD, PhD^12,13, Charalambos Andreadis, MD, MSCE^14*, Peter A. Riedell, MD^15*, Phoebe Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA)^16*, Jose A. Perez-Simon, MD, PhD¹⁷, Andy Chen, MD, PhD¹⁸, Loretta J. Nastoupil, MD¹⁹, Bastian von Tresckow, MD²⁰, Andrés J M Ferreri, MD²¹, Takanori Teshima, M.D., Ph.D.²², Piers E.M. Patten^23,24*, Joseph P. McGuirk, DO²⁵, Andreas Petzer, MD²⁶, Fritz Offner, MD, PhD²⁷, Andreas Viardot, MD²⁸, Pier Luigi Zinzani, MD, PhD^29,30, Ram Malladi, MD^31*, Ines Paule^32*, Aiesha Zia^32*, Rakesh Awasthi, PhD^33*, Xia Han, MS^34*, Davide Germano^32*, Darragh O'Donovan, PhD^35*, Roberto Ramos, MD^34*, Aisha Masood, MD³⁴, Catherine Thieblemont, MD, PhD³⁶, Nathan H. Fowler, MD³⁷ and Stephen J. Schuster, MD^38*

¹Medizinische Klinik III, LMU Klinikum, Munich, Germany
²Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia
³Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
⁴Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
⁵Department of Haematology and BMT, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
⁶Michigan Medicine University of Michigan, Ann Arbor, MI
⁷Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸Moffitt Cancer Center, University of South Florida, Tampa, FL
⁹Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
¹⁰Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
¹¹Tohoku University Hospital, Sendai, Japan
¹²On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam, Netherlands, Amsterdam, Netherlands
¹³University of Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
¹⁴Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
¹⁵The University of Chicago Comprehensive Cancer Center, Chicago, IL
¹⁶Royal Prince Alfred Hospital and University of Sydney, Camperdown, Sydney, NSW, Australia
¹⁷Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
¹⁸Oregon Health and Science University, Portland, OR
¹⁹The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Department I of Internal Medicine, West German Cancer Center Essen, Essen, Germany
²¹Lymphoma Unit, Dept of Onco-hematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
²²Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
²³Comprehensive Cancer Centre, King’s College London, London, United Kingdom
²⁴Department of Haematology, King’s College Hospital, London, United Kingdom
²⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
²⁶Internal Medicine I, Ordensklinikum Linz GmbH Elisabethinen, Linz, Austria
²⁷UZ Gent, Gent, Belgium
²⁸Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
²⁹Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
³⁰IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
³¹Cambridge University Hospitals NHS Foundation Trust, Cambridge, CA, United Kingdom
³²Novartis Pharma AG, Basel, Switzerland
³³Novartis Institutes for BioMedical Research, East Hanover, NJ
³⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ
³⁵Novartis Pharmaceuticals Corporation, Dublin, Ireland
³⁶Hôpital Saint-Louis, Paris, France
³⁷The University of Texas, MD Anderson Cancer Center, Houston, TX
³⁸Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Lorenzo Falchi, MD¹, Pau Abrisqueta, MD, PhD^2*, Marcel Nijland, MD, PhD^3*, Sirpa Leppä, MD, PhD⁴, Martin Hutchings, MD, PhD^5*, Harald Holte, MD, PhD^6,7, Reid W. Merryman, MD⁸, Pieternella Lugtenburg, MD, PhD⁹, Sven de Vos, MD, PhD¹⁰, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc¹¹, Jacob Haaber Christensen, MD, PhD^12*, Luca Arcaini^13,14*, Kristina Drott, MD, PhD^15*, Mats Hellström, MD, PhD^16*, Lori A. Leslie, MD^17*, Umberto Vitolo, MD¹⁸, Ali Rana, MD, PhD^19*, Aqeel Abbas, MS^19*, Liwei Wang, PhD^19*, Minh Dinh, MD^20* and David Belada, MD, PhD^21*

¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Hospital Universitari Vall d’Hebron, Barcelona, Spain
³Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⁴Helsinki University Hospital Cancer Center, Helsinki, Finland
⁵Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
⁶Oslo University Hospital, Oslo, Norway
⁷KG. Jebsen Centre for B cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Department of Hematology, On behalf of the HOVON lymphoma working group, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
¹⁰Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA
¹¹Sir Charles Gairdner Hospital, Nedlands, Australia
¹²Odense University Hospital, Odense, Denmark
¹³Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁴Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹⁵Skåne University Hospital, Lund, Sweden
¹⁶Uppsala University Hospital, Uppsala, Sweden
¹⁷Hackensack University Medical Center, Hackensack, NJ
¹⁸Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
¹⁹Genmab, Princeton, NJ
²⁰AbbVie, Inc., North Chicago, IL
²¹4th Department of Internal Medicine – Hematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic

Nancy L. Bartlett^1*, Laurie H. Sehn, MD, MPH², Matthew J. Matasar, MD, MS³, Stephen J. Schuster^4*, Sarit Assouline⁵, Pratyush Giri^6*, John Kuruvilla, MD⁷, Miguel Canales, MD, PhD⁸, Sascha Dietrich, M.D.⁹, Keith Fay^10*, Matthew Ku, MBBS PhD¹¹, Loretta J. Nastoupil, MD¹², Michael C. Wei^13*, Shen Yin¹³, Iris To^13*, Huang Huang^14*, Juliana Min^15*, Elicia Penuel^13* and Elizabeth L. Budde, MD, PhD¹⁶

¹Siteman Cancer Center, Washington University School of Medicine, St Louis, MO
²BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Jewish General Hospital, McGill University, Montreal, QC, Canada
⁶Royal Adelaide Hospital, Adelaide, Australia
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Hospital Universitario La Paz, Madrid, Spain
⁹Universitat Heidelberg, Heidelberg, Germany
¹⁰St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
¹¹St Vincent's Hospital, University of Melbourne, Melbourne, Australia
¹²MD Anderson Cancer Center, Houston, TX
¹³Genentech, Inc., South San Francisco, CA
¹⁴F. Hoffmann-La Roche Ltd, Mississauga, Canada
¹⁵Roche Products Ltd, Welwyn Garden City, United Kingdom
¹⁶Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Lorenzo Falchi, MD¹, Lori A. Leslie, MD^2*, David Belada, MD, PhD^3*, Katerina Kopeckova, MD, PhD^4*, Fritz Offner, MD, PhD⁵, Joshua Brody, MD⁶, Miguel Canales, MD, PhD⁷, Alejandro Martín García-Sancho, MD, PhD^8*, Marcel Nijland, MD, PhD^9*, P-O Andersson, MD, PhD^10*, Farrukh T. Awan, M.D.¹¹, Jacob Haaber Christensen, MD, PhD^12*, Kristina Drott, MD, PhD^13*, Mats Hellström, MD, PhD^14*, Catharina Lewerin, MD, PhD^15*, Mayur Narkhede, MBBS¹⁶, Sylvia Snauwaert, MD, PhD^17*, Björn E Wahlin, MD, PhD¹⁸, Ali Rana, MD, PhD^19*, Aqeel Abbas, MS^19*, Liwei Wang, PhD^19*, Minh Dinh, MD^20*, Joost S.P. Vermaat, MD, PhD²¹ and Pau Abrisqueta, MD, PhD^22*

¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Hackensack University Medical Center, Hackensack, NJ
³4th Department of Internal Medicine – Hematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
⁴Fakultni nemocnice v Motole, Prague, Czech Republic
⁵Universitair Ziekenhuis Gent, Ghent, Belgium
⁶Icahn School of Medicine at Mount Sinai, New York, NY
⁷Hospital Universitario La Paz, Madrid, Spain
⁸Hospital Universitario de Salamanca, Salamanca, Spain
⁹Department of Hematology, University Medical Center Groningen and University of Groningen, Groningen, Netherlands
¹⁰Södra Älvsborgs Sjukhus, Borås, Sweden
¹¹University of Texas Southwestern Medical Center, Dallas, TX
¹²Odense University Hospital, Odense, Denmark
¹³Skåne University Hospital, Lund, Sweden
¹⁴Uppsala University Hospital, Uppsala, Sweden
¹⁵Sahlgrenska University Hospital, Goeteborg, Sweden
¹⁶O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL
¹⁷Department of Hematology, AZ Sint-Jan Brugge, Brugge, Belgium
¹⁸Karolinska Institute, Stockholm, Sweden
¹⁹Genmab, Princeton, NJ
²⁰AbbVie, Inc., North Chicago, IL
²¹Department of Hematology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
²²Hospital Universitari Vall d’Hebron, Barcelona, Spain

Jing-Zhou Hou, MD, PhD¹, Ryan Jacobs, MD^2*, Seok-Goo Cho, M.D., Ph.D.^3*, Sumana Devata, MD⁴, Sameh Gaballa, MD⁵, Dok Hyun Yoon, MD, PhD^6*, Don A. Stevens, MD⁷, Jin Seok Kim, MD, PhD^8*, Ben Buelow, MD, PhD⁹ and Ranjit Nair, MD¹⁰

¹Hematology and BMT, Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
²Hematology, Atrium Health Levine Cancer Institute, Charlotte, NC
³Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁴Internal Medicine/Hematology/Oncology, University of Michigan, Milwaukee, WI
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁷Norton Cancer Institute, Norton Health Care, Louisville, KY
⁸Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
⁹Ancora Biotech, Inc., San Francisco, CA
¹⁰Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX